Ac-Leu-NHMe

Ac-Leu-NHMe is an N-acetylated leucine derivative featuring a C-terminal N-methylamide (NHMe), providing a neutral, peptide-like amide functionality that is commonly used to model or cap the leucine residue in small peptides. With the L-leucine side chain (isobutyl) retained, this compound is frequently handled as a defined building block for structure-property studies, conformational benchmarking, and method development where a protected, non-hydrolyzable terminal amide is advantageous. Its blocked termini reduce competing reactivity relative to free amino acids, making it a practical reagent for downstream peptide and peptidomimetic workflows that require a specific leucine environment.

1. Peptide Fragment Modeling

Ac-Leu-NHMe is used as a defined leucine-containing fragment for peptide fragment modeling in chemical biology and peptide chemistry, particularly when researchers want to study local backbone effects without introducing free N- or C-termini. By presenting an N-acetyl group and a C-terminal N-methylamide, the compound helps standardize hydrogen-bonding patterns and terminal charge states in small-molecule or short-peptide analogs. This makes it useful for benchmarking synthesis strategies, comparing conformational preferences across leucine variants, and generating consistent reference materials for analytical characterization such as LC-MS and NMR.

2. Peptidomimetic Intermediate Development

Ac-Leu-NHMe serves as a practical intermediate building block in peptidomimetic development where leucine is incorporated as a stable, capped residue. Medicinal chemistry and process development teams frequently use such capped amino acid derivatives to assemble larger amide-rich scaffolds while minimizing side reactions associated with terminal functional groups. The N-methylamide end is particularly helpful when the target design requires a non-ionizable terminal amide motif that behaves predictably during coupling steps and downstream purification, supporting the preparation of analog libraries and structure-activity relationship (SAR) series that include leucine as a key hydrophobic element.

3. Analytical Standard And Method Checks

Ac-Leu-NHMe is also used as a reference compound for analytical method development and troubleshooting in workflows that monitor peptide-like species. Because it is a well-defined leucine derivative with blocked termini, it can function as a stable standard for verifying retention behavior, ionization response, and fragmentation patterns in LC-MS/MS assays that include amino acid amide motifs. Analytical groups often select this type of compound when they need a consistent, non-degrading benchmark for sample prep checks, instrument qualification, or comparative quantitation of leucine-containing fragments in synthetic reaction monitoring and impurity profiling.

1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

2. Emu oil in combination with other active ingredients for treating skin imperfections

3. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

4. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

5. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment